Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668648 | SCV000793282 | pathogenic | Fanconi anemia complementation group A | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001211107 | SCV001382631 | pathogenic | Fanconi anemia | 2024-06-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys34*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is present in population databases (rs772858764, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 15643609, 22778927). ClinVar contains an entry for this variant (Variation ID: 553243). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000668648 | SCV002797816 | pathogenic | Fanconi anemia complementation group A | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000668648 | SCV004196078 | pathogenic | Fanconi anemia complementation group A | 2024-03-21 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000668648 | SCV001426016 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Johan de Winter. |